Irakurle konpetenteak lortze aldera

[EUS] Irakurriaren ulermenaren eremu ezin zabalagora hurbiltzeko hainbat arlo ukituko ditugu artikulu honetan. Lehenik eta behin, gai honen gaineko garraztasunak arintzeko Wiki bat diseinatu dugu eta bertan hainbat atal ikuskatuko ditugu. Wiki hau, Lehen Hezkuntzako nahiz DBHko hainbat irakasleekin landu da, beti ere, irakurriaren ulermena eskolan zertan hobetu daitekeen ikusteko. Beraz, artikuluarekin batera wikiaren jarraipena egitea gomendatzen da. Hona hemen helbidea: www.letutaletu.wikispaces.com . Artikulu honek lau atal aski diferente izango ditu. Atal hauen helbururik behiena, Lehen Hezkuntzako hirugarren zikloko nahiz DBHko lehenengo zikloko irakasleei zein ikasleei irakurriaren ulermenaren gaineko hainbat lanabes praktiko ematea litzateke. Horretarako, lehen atalean, eskolak irakurriaren ulermenaren gainean diagnosia egin dezan hainbat gogoeta ekarpen gisara planteatuko dira. Bigarrenik, irakasleek klaseetan irakurketa estrategiak lan ditzaten lan eskema bat proposatuko da. Hirugarrenik, azalpen testuek dituzten zailtasunen inguruan hausnartuko da eta zailtasun horiek gainditze aldera irakasleari hainbat erreminta emango zaizkio. Eta azkenik, bibliografiak edota irakurketak errazteko hainbat ekarpen egingo dira.

Herramientas para desarrollar el hábito lector en la escuela y la familia

Losada Iglesias, Daniel; Correa Gorospe, José Miguel (eds.)

La inversión socialmente responsable en los fondos de pensiones y en las EPSV de empleo

Máster en Dirección Empresarial desde la Innovación y la internacionalización. Curso 2013/2014

A Delphi Process to Optimize Quality and Performance of Drug Evaluation in Neonates

Background: Neonatal trials remain difficult to conduct for several reasons: in particular the need for study sites to have an existing infrastructure in place, with trained investigators and validated quality procedures to ensure good clinical, laboratory practices and a respect for high ethical standards. The objective of this work was to identify the major criteria considered necessary for selecting neonatal intensive care units that are able to perform drug evaluations competently. Methodology and Main Findings: This Delphi process was conducted with an international multidisciplinary panel of 25 experts from 13 countries, selected to be part of two committees (a scientific committee and an expert committee), in order to validate criteria required to perform drug evaluation in neonates. Eighty six items were initially selected and classified under 7 headings: "NICUs description - Level of care'' (21), "Ability to perform drug trials: NICU organization and processes (15), "Research Experience'' (12), "Scientific competencies and area of expertise'' (8), "Quality Management'' (16), "Training and educational capacity'' (8) and "Public involvement'' (6). Sixty-one items were retained and headings were rearranged after the first round, 34 were selected after the second round. A third round was required to validate 13 additional items. The final set includes 47 items divided under 5 headings. Conclusion: A set of 47 relevant criteria will help to NICUs that want to implement, conduct or participate in drug trials within a neonatal network identify important issues to be aware of. Summary Points: 1) Neonatal trials remain difficult to conduct for several reasons: in particular the need for study sites to have an existing infrastructure in place, with trained investigators and validated quality procedures to ensure good clinical, laboratory practices and a respect for high ethical standards. 2) The present Delphi study was conducted with an international multidisciplinary panel of 25 experts from 13 countries and aims to identify the major criteria considered necessary for selecting neonatal intensive care units (NICUs) that are able to perform drug evaluations competently. 3) Of the 86 items initially selected and classified under 7 headings - "NICUs description - Level of care'' (21), "Ability to perform drug trials: NICU organization and processes (15), "Research Experience'' (12), "Scientific competencies and area of expertise'' (8), "Quality Management'' (16), "Training and educational capacity'' (8) and "Public involvement'' (6) - 47 items were selected following a three rounds Delphi process. 4) The present consensus will help NICUs to implement, conduct or participate in drug trials within a neonatal network.